James E Haddow1, Wendy Y Craig, Louis M Neveux, Hamish R M Haddow, Glenn E Palomaki, Geralyn Lambert-Messerlian, Fergal D Malone, Mary E D'Alton. 1. Women and Infants Hospital and Alpert Medical School of Brown University (J.E.H., L.M.N., G.E.P., G.L.-M.), Providence, Rhode Island 02903; Savjani Institute for Health Research (J.E.H., L.M.N., H.R.M.H., G.E.P.), Windham, Maine 04062; Foundation for Blood Research (W.Y.C.), Scarborough, Maine 04070; Columbia University College of Physicians and Surgeons (F.D.M., M.E.D.), New York, New York 10032; and Royal College of Surgeons in Ireland (F.D.M.), Dublin 2, Ireland.
Abstract
CONTEXT: Lower birth weight has been reported in conjunction with high maternal free T4 (FT4) in euthyroid pregnancies, raising concerns for suboptimal outcomes. OBJECTIVE: The objective of the study was to explore the relationships between high maternal FT4 and pregnancy complications in euthyroid women and to further examine the relationships among maternal size, FT4, and birth weight. DESIGN: This was an observational multicenter cohort study. SETTING: The study was conducted at prenatal clinics. STUDY SUBJECTS: A total of 9209 euthyroid women with singleton pregnancies participated in the study. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURES: Relationships between second-trimester high maternal FT4 and pregnancy/delivery complications and, among FT4, maternal weight and birth weight were measured. RESULTS: Women in the highest FT4 quintile are younger and weigh less than women in quintiles 1-4; gestational diabetes and preeclampsia occur less often (P = < .001, P < .001, P < .001, and P = .05, respectively). Lowest median birth weight occurs among women in the highest FT4 quintile (P = < .001), but deliveries less than 37 weeks' gestation are not increased. Labor/delivery complications do not differ by FT4 quintile. Restricting analyses to maternal weight-adjusted small-for-gestational-age deliveries yields similar results, except for preeclampsia. In the highest maternal weight decile, adjusted median birth weight is 266 g higher (8.3%) than in the lowest weight decile; adjusted median FT4 is 0.91 pmol/L lower (6.8%). Among women in the highest FT4 decile, adjusted median birth weight is 46 g lower (1.3%) than in the lowest FT4 decile. All three relationships are statistically significant (P < .001, P < .001, and P = .004, respectively). CONCLUSIONS: Lower median birth weight among euthyroid women with high FT4 is not associated with adverse pregnancy outcomes. Further investigation is indicated to determine how the variations in thyroid hormone concentration influence birth weight.
CONTEXT: Lower birth weight has been reported in conjunction with high maternal free T4 (FT4) in euthyroid pregnancies, raising concerns for suboptimal outcomes. OBJECTIVE: The objective of the study was to explore the relationships between high maternal FT4 and pregnancy complications in euthyroid women and to further examine the relationships among maternal size, FT4, and birth weight. DESIGN: This was an observational multicenter cohort study. SETTING: The study was conducted at prenatal clinics. STUDY SUBJECTS: A total of 9209 euthyroid women with singleton pregnancies participated in the study. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURES: Relationships between second-trimester high maternal FT4 and pregnancy/delivery complications and, among FT4, maternal weight and birth weight were measured. RESULTS:Women in the highest FT4 quintile are younger and weigh less than women in quintiles 1-4; gestational diabetes and preeclampsia occur less often (P = < .001, P < .001, P < .001, and P = .05, respectively). Lowest median birth weight occurs among women in the highest FT4 quintile (P = < .001), but deliveries less than 37 weeks' gestation are not increased. Labor/delivery complications do not differ by FT4 quintile. Restricting analyses to maternal weight-adjusted small-for-gestational-age deliveries yields similar results, except for preeclampsia. In the highest maternal weight decile, adjusted median birth weight is 266 g higher (8.3%) than in the lowest weight decile; adjusted median FT4 is 0.91 pmol/L lower (6.8%). Among women in the highest FT4 decile, adjusted median birth weight is 46 g lower (1.3%) than in the lowest FT4 decile. All three relationships are statistically significant (P < .001, P < .001, and P = .004, respectively). CONCLUSIONS: Lower median birth weight among euthyroid women with high FT4 is not associated with adverse pregnancy outcomes. Further investigation is indicated to determine how the variations in thyroid hormone concentration influence birth weight.
Authors: Ritesh V Agnihothri; Amber B Courville; Joyce D Linderman; Sheila Smith; Robert Brychta; Alan Remaley; Kong Y Chen; Louis Simchowitz; Francesco S Celi Journal: Thyroid Date: 2014-01 Impact factor: 6.568
Authors: Geralyn Lambert-Messerlian; Monica McClain; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton Journal: Am J Obstet Gynecol Date: 2008-07 Impact factor: 8.661
Authors: Jane Cleary-Goldman; Fergal D Malone; Geralyn Lambert-Messerlian; Lisa Sullivan; Jacob Canick; T Flint Porter; David Luthy; Susan Gross; Diana W Bianchi; Mary E D'Alton Journal: Obstet Gynecol Date: 2008-07 Impact factor: 7.661
Authors: L Ay; C J Kruithof; R Bakker; E A P Steegers; J C M Witteman; H A Moll; A Hofman; J P Mackenbach; A C S Hokken-Koelega; V W V Jaddoe Journal: BJOG Date: 2009-04-15 Impact factor: 6.531
Authors: Carmen Messerlian; Joseph M Braun; Lidia Mínguez-Alarcón; Paige L Williams; Jennifer B Ford; Vicente Mustieles; Antonia M Calafat; Irene Souter; Thomas Toth; Russ Hauser Journal: Environ Int Date: 2017-06-27 Impact factor: 9.621
Authors: Lauren E Johns; Kelly K Ferguson; David E Cantonwine; Bhramar Mukherjee; John D Meeker; Thomas F McElrath Journal: J Clin Endocrinol Metab Date: 2018-04-01 Impact factor: 5.958
Authors: Arash Derakhshan; Robin P Peeters; Peter N Taylor; Sofie Bliddal; David M Carty; Margreet Meems; Bijay Vaidya; Liangmiao Chen; Bridget A Knight; Farkhanda Ghafoor; Polina V Popova; Lorena Mosso; Emily Oken; Eila Suvanto; Aya Hisada; Jun Yoshinaga; Suzanne J Brown; Judit Bassols; Juha Auvinen; Wichor M Bramer; Abel López-Bermejo; Colin M Dayan; Robert French; Laura Boucai; Marina Vafeiadi; Elena N Grineva; Victor J M Pop; Tanja G Vrijkotte; Leda Chatzi; Jordi Sunyer; Ana Jiménez-Zabala; Isolina Riaño; Marisa Rebagliato; Xuemian Lu; Amna Pirzada; Tuija Männistö; Christian Delles; Ulla Feldt-Rasmussen; Erik K Alexander; Scott M Nelson; Layal Chaker; Elizabeth N Pearce; Mònica Guxens; Eric A P Steegers; John P Walsh; Tim I M Korevaar Journal: Lancet Diabetes Endocrinol Date: 2020-06 Impact factor: 44.867
Authors: James E Haddow; Wendy Y Craig; Louis M Neveux; Glenn E Palomaki; Geralyn Lambert-Messerlian; Fergal D Malone; Mary E D'Alton Journal: PLoS One Date: 2016-02-24 Impact factor: 3.240